There is a perception that etanercept has a lower risk of serious infection than other biologics based on lower rates of tuberculosis, extrapolation from the rheumatoid arthritis literature (Galloway et al., 2011), and the general assumption that a less efficacious tumor necrosis factor inhibitors would be safer. Here, TNF is linked to rheumatoid arthritis.